ATE536889T1 - Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten - Google Patents

Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten

Info

Publication number
ATE536889T1
ATE536889T1 AT04756747T AT04756747T ATE536889T1 AT E536889 T1 ATE536889 T1 AT E536889T1 AT 04756747 T AT04756747 T AT 04756747T AT 04756747 T AT04756747 T AT 04756747T AT E536889 T1 ATE536889 T1 AT E536889T1
Authority
AT
Austria
Prior art keywords
platelet
individual
activation
platembocyte
controlled
Prior art date
Application number
AT04756747T
Other languages
English (en)
Inventor
Barry S Coller
Dennis Durbin
Original Assignee
Accumetrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accumetrics Inc filed Critical Accumetrics Inc
Application granted granted Critical
Publication of ATE536889T1 publication Critical patent/ATE536889T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04756747T 2003-07-08 2004-07-06 Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten ATE536889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48570303P 2003-07-08 2003-07-08
PCT/US2004/021785 WO2005007868A2 (en) 2003-07-08 2004-07-06 Controlled platelet activation to monitor therapy of adp antagonists

Publications (1)

Publication Number Publication Date
ATE536889T1 true ATE536889T1 (de) 2011-12-15

Family

ID=34079156

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04756747T ATE536889T1 (de) 2003-07-08 2004-07-06 Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten

Country Status (5)

Country Link
US (4) US7790362B2 (de)
EP (1) EP1641492B1 (de)
AT (1) ATE536889T1 (de)
ES (1) ES2378544T3 (de)
WO (1) WO2005007868A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
DE102006020385A1 (de) * 2006-04-28 2007-10-31 Dade Behring Marburg Gmbh Verfahren und Vorrichtung zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen
DE102006020386A1 (de) 2006-04-28 2007-10-31 Dade Behring Marburg Gmbh Verfahren zur Bestimmung der Thrombozytenfunktion unter Flussbedingungen
EP2153235B1 (de) * 2007-05-03 2012-05-16 Accumetrics, Inc. Verfahren zur messung der thrombozytenaggregationshemmung mittels thrombinrezeptorantagonisten
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
WO2009152094A2 (en) * 2008-06-09 2009-12-17 Accumetrics, Inc. Hubbed dual cannula device for closed container sampling systems
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
US20110165595A1 (en) * 2009-07-13 2011-07-07 Catanzaro Brian E Apparatus and methods for processing a whole blood sample
JP5768422B2 (ja) * 2011-03-17 2015-08-26 ソニー株式会社 血液凝固系解析方法および血液凝固系解析装置
EP2508892A1 (de) * 2011-04-04 2012-10-10 Siemens Healthcare Diagnostics Products GmbH Kontrollen und Kit für Thrombozytenaktivitätsteste
WO2013013228A1 (en) * 2011-07-21 2013-01-24 Invitrox, Inc. Methods for determining patient response to anti-platelet aggregation therapy
WO2015065986A1 (en) * 2013-10-29 2015-05-07 Bloodcenter Research Foundation Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
US10816559B2 (en) 2014-09-29 2020-10-27 Ca Casyso Ag Blood testing system and method
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
KR101899782B1 (ko) 2016-12-19 2018-09-20 원광대학교산학협력단 페닐알라닌-클로로퀸 유도체 화합물을 유효성분으로 함유하는 말라리아 감염 질환의 예방 또는 치료용 조성물

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518057A (en) 1966-04-22 1970-06-30 Huron Road Hospital Method and apparatus for thrombus formation time determinations
US3694161A (en) 1971-04-14 1972-09-26 Armour Pharma Method for measuring platelet aggregation
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4051236A (en) * 1973-02-15 1977-09-27 E. R. Squibb & Sons, Inc. Inhibition of blood platelet aggregation
NO750542L (de) 1974-02-21 1975-08-22 Braun Melsungen Ag
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
JPS5697226A (en) * 1979-12-28 1981-08-05 Mitsubishi Chem Ind Ltd Blood platelet coagulation inhibitor
US4622293A (en) 1983-07-05 1986-11-11 Miles Laboratories, Inc. Iodothyronine immunoassays employing HMS as TBP blocking agent
US4717654A (en) 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
US4634681A (en) * 1984-10-29 1987-01-06 General Electric Company Diagnostic method of determining the presence or absence of select proteins in a liquid sample
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4948961A (en) * 1985-08-05 1990-08-14 Biotrack, Inc. Capillary flow device
CA1284642C (en) * 1986-03-31 1991-06-04 Hikozo Iwakura Prostacyclin (pgi ) analogues
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5066592A (en) * 1988-03-08 1991-11-19 Temple University Of The Commonwealth System Of Higher Education Trigramin - a platelet aggregation inhibiting polypeptide
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
AU649673B2 (en) * 1990-04-30 1994-06-02 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of arachidonic acid metabolism
US5246832A (en) * 1990-06-20 1993-09-21 University Of Massachusetts Medical Center Platelet analysis in whole blood
US5196309A (en) 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
AU7112794A (en) 1993-06-18 1995-01-17 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5455228A (en) 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
IL106330A (en) * 1993-07-14 1998-01-04 Univ Ramot Method and instrument for determining the activity of their plaques in the initial coagulation system
US5486361A (en) * 1993-10-25 1996-01-23 The United States Of America As Represented By The Department Of Health And Human Services Hybridomas and monoclonal antibodies that speifically bind to GPIB on platelets and inhibit the binding of thrombin to platelets
DE4344919A1 (de) 1993-12-30 1995-07-06 Behringwerke Ag Verfahren zur Bestimmung der Thrombozytenaggregation
WO1995027209A1 (en) 1994-03-31 1995-10-12 The Trustees Of The University Of Pennsylvania Method and kit for detection of thrombin receptor activation of platelets and other cells
ES2139957T3 (es) 1994-07-23 2000-02-16 Roche Diagnostics Gmbh Metodo para la determinacion del estado pretrombotico.
US5763199A (en) 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
FR2744918B1 (fr) * 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
US5753517A (en) * 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6221672B1 (en) 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
US6043871A (en) 1997-03-03 2000-03-28 Brigham Young University System and method for measuring blood platelet function
US5922551A (en) 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6016712A (en) 1997-09-18 2000-01-25 Accumetrics Device for receiving and processing a sample
US6210904B1 (en) * 1997-10-14 2001-04-03 Merck & Co., Inc. Anticoagulant test
KR100569319B1 (ko) 1997-10-30 2006-04-07 모리시타 진탄 가부시키가이샤 불포화 지방산 또는 이들의 유도체를 내용물로 하는 캡슐제제 및 그의 제조방법
US6063847A (en) 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
USD409758S (en) 1998-01-14 1999-05-11 Accumetrics Sample cartridge
AU2672899A (en) 1998-02-27 1999-09-15 Regents Of The University Of California, The Protease-activated receptor 4 and uses thereof
EP0964046B1 (de) 1998-06-03 2003-07-30 Mitsubishi Gas Chemical Company, Inc. Sauerstoffabsorbierende Zusammensetzung, Sauerstoffabsorbierendes Harz und Konservierungsverfahren
US6093370A (en) * 1998-06-11 2000-07-25 Hitachi, Ltd. Polynucleotide separation method and apparatus therefor
WO2000015214A1 (en) * 1998-09-11 2000-03-23 Ilexus Pty Limited Fc RECEPTOR MODULATORS AND USES THEREOF
WO2000025140A1 (en) 1998-10-23 2000-05-04 Accumetrics, Inc. Method for determining platelet count
AU5044400A (en) 1999-05-28 2000-12-18 Sendx Medical, Inc. Control for methods for determining platelet count and platelet function
EP1216037A2 (de) * 1999-09-21 2002-06-26 Emory University Verfahren und zusammensetzungen zur behandlung von bluttplätchen-zusammenhängenden krankheiten, mit mpl hemmenden agenten
US6589992B2 (en) 1999-11-30 2003-07-08 Parker Hughes Institute Inhibiting collagen-induced platelet aggregation
DE60115227T2 (de) * 2000-05-11 2006-08-24 Bristol-Myers Squibb Co. Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
AU6690001A (en) 2000-06-15 2001-12-24 Schering Corp Thrombin receptor antagonists
US20020077693A1 (en) * 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
AU2001294861A1 (en) * 2000-09-29 2002-04-08 Endovasc Ltd., Inc. Resorbable prosthesis for medical treatment
ES2282304T3 (es) 2000-11-01 2007-10-16 Astellas Pharma Inc. Procedimiento para seleccionar antiplaquetas.
US6841354B2 (en) * 2000-12-21 2005-01-11 Philadelphia, Health & Education Corporation Screening assay for anti-thrombotic/anti-platelet activity
EP1394152A4 (de) 2001-04-19 2005-02-02 Eisai Co Ltd 2-iminoimidazolderivate (1)
US20030148264A1 (en) * 2001-07-06 2003-08-07 Genentech, Inc. Phage displayed PDZ domain ligands
KR100960170B1 (ko) 2001-10-18 2010-05-26 쉐링 코포레이션 트롬빈 수용체 길항제로서의 힘바신 동족체
US6833536B2 (en) * 2002-05-22 2004-12-21 Applera Corporation Non-contact radiant heating and temperature sensing device for a chemical reaction chamber
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
AU2003277398A1 (en) 2002-10-15 2004-05-04 The University Of Tennessee Research Foundation Methods for assessment of platelet aggregation
US7125815B2 (en) * 2003-07-07 2006-10-24 Micron Technology, Inc. Methods of forming a phosphorous doped silicon dioxide comprising layer
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US7595169B2 (en) 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US7205115B2 (en) 2005-04-28 2007-04-17 Accumetrics, Inc. Method and system for stabilization of arachidonic acid for use in platelet function assay
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
EP2153235B1 (de) 2007-05-03 2012-05-16 Accumetrics, Inc. Verfahren zur messung der thrombozytenaggregationshemmung mittels thrombinrezeptorantagonisten
EP2227559B1 (de) 2007-11-30 2018-08-29 QIAGEN Instruments AG Vorrichtung für thermisches cycling

Also Published As

Publication number Publication date
US8574828B2 (en) 2013-11-05
US7790362B2 (en) 2010-09-07
EP1641492A4 (de) 2009-08-19
WO2005007868A2 (en) 2005-01-27
ES2378544T3 (es) 2012-04-13
EP1641492B1 (de) 2011-12-14
EP1641492A2 (de) 2006-04-05
US20110081657A1 (en) 2011-04-07
WO2005007868A3 (en) 2005-08-18
US20110065125A1 (en) 2011-03-17
US9341637B2 (en) 2016-05-17
US20140234859A1 (en) 2014-08-21
US20050031616A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE536889T1 (de) Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
Steen et al. The platelet-stimulating effect of adrenaline through α2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist
Wilson et al. Mode-switching of a voltage-gated cation channel is mediated by a protein kinase A-regulated tyrosine phosphatase
Chow et al. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation
Dardik et al. Homocysteine and oxidized low density lipoprotein enhance platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation
Lüthi et al. Hippocampal long-term potentiation and neural cell adhesion molecules L1 and NCAM
Sharfe et al. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions
Barnes et al. The collagen-platelet interaction
DK0783696T3 (da) Blodpladeblokadeassay
Navdaev et al. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (Malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ2, but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor
ATE481501T1 (de) Verfahren und system zur absoluten bestimmung einer prozentualen plättchenhäufung
Moroi et al. Involvement of activated integrin α2β1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions
Quinton et al. Glycoprotein VI–mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP
DE60139618D1 (de) Verfahren und vorrichtung zur überwachung von antiblutplättchenagenzien
Sarray et al. Lebectin and lebecetin, two C-type lectins from snake venom, inhibit α5β1 and αv-containing integrins
Carroll et al. Measurement of functional fibrinogen levels using the Thrombelastograph
Whelihan et al. Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation
Modderman et al. A monoclonal antibody to the human platelet glycoprotein II b/III a complex induces platelet activation
Naganuma et al. Cleavage of platelet endothelial cell adhesion molecule‐1 (PECAM‐1) in platelets exposed to high shear stress
Chow et al. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation
Matsumoto et al. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses
Berridge Electrophysiological evidence for the existence of separate receptor mechanisms mediating the action of 5-hydroxytryptamine
Strukova et al. Thrombin-mediated events implicated in mast cell activation
Vigne et al. Diadenosine polyphosphates as antagonists of the endogenous P2Y1 receptor in rat brain capillary endothelial cells of the B7 and B10 clones
Yu et al. Microfluidic hemophilia models using blood from healthy donors